D.E. Shaw & Co
JBIO

D.E. Shaw & Co’s Jade Biosciences JBIO Stock Holding History

D.E. Shaw & Co’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
+51,494
New +$1.07M ﹤0.01% 3658
2024
Q2 		– Sell
-493
Closed -$511K – 4477
2024
Q1 		$511K Buy
+493
New +$377K ﹤0.01% 3477
2023
Q2 		– Sell
-456
Closed -$322K – 4224
2023
Q1 		$322K Sell
456
-387
-46% -$321K ﹤0.01% 3730
2022
Q4 		$864K Sell
843
-137
-14% -$99.5K ﹤0.01% 3542
2022
Q3 		$569K Buy
+980
New +$654K ﹤0.01% 3963

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co's JBIO Position: Q2 2026 in Review

D.E. Shaw & Co opened a new position in Jade Biosciences (JBIO) in Q2 2026: 51,494 shares worth $1.14M. The stake represents ﹤0.01% of the portfolio and ranks #3658 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in JBIO as recently as Q1 2024.

D.E. Shaw & Co first reported a position in JBIO in Q3 2022 and has held it in 5 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • D.E. Shaw & Co held 51,494 shares of Jade Biosciences worth $1.14M as of Q2 2026.
  • Jade Biosciences was a new D.E. Shaw & Co position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #3658 holding.
  • D.E. Shaw & Co first reported a position in Jade Biosciences in Q3 2022 and has held it in 5 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.